Iron nanoparticle could light up brain inflammation on MRI
NCT ID NCT02511028
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 27 times
Summary
This study looked at whether ferumoxytol, an iron-based contrast agent, can help spot inflammation in the brains of people with multiple sclerosis (MS) using a powerful 7 Tesla MRI. Fourteen participants (some with MS, some healthy) received ferumoxytol and had multiple MRI scans over six months. The goal was to see if the drug causes long-lasting changes on MRI and if it can reveal inflammation better than standard methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.